Skip to main content
OpenTrials
Not yet recruiting

NCT Number: NCT07820267

Dynamic POCUS of Diaphragm Function to Predict Respiratory Failure in Septic Shock

This prospective observational cohort study aims to evaluate the prognostic value of serial bedside ultrasound assessment of diaphragmatic function in adult patients with septic shock. Diaphragmatic excursion, thickness, and thickening fraction will be assessed using point of care ultrasound at baseline and serially during the first 72 hours of intensive care admission. Dynamic changes in these parameters will be analyzed in relation to the development of respiratory failure, need for invasive mechanical ventilation, duration of mechanical ventilation, weaning and extubation outcomes, length of ICU stay, and mortality. The study will determine whether dynamic diaphragmatic ultrasound assessment can provide an early, non-invasive predictor of respiratory failure and adverse clinical outcomes in patients with septic shock.

Not yet recruiting

Trial opening soon.

Get Notified

Key information

About this study

Septic shock remains a major cause of morbidity and mortality among critically ill patients. Respiratory failure is a frequent and serious complication, resulting from a combination of sepsis-induced lung injury, acute respiratory distress syndrome, respiratory muscle dysfunction, and sepsis-induced myopathy. The diaphragm is the principal muscle of respiration and may be significantly affected during sepsis. Systemic inflammation, altered microcirculation, mitochondrial dysfunction, electrolyte abnormalities, prolonged immobilization, sedation, and mechanical ventilation can contribute to diaphragmatic dysfunction. Such dysfunction may impair spontaneous breathing, increase the risk of respiratory failure, prolong mechanical ventilation, and contribute to unsuccessful weaning and adverse clinical outcomes. Point-of-care ultrasound (POCUS) provides a non-invasive, bedside, radiation-free method for assessing diaphragmatic structure and function. The most commonly used parameters include diaphragmatic excursion (DE), diaphragmatic thickness, and diaphragmatic thickening fraction (DTF). Most available studies have assessed diaphragmatic function at a single point in time, particularly during weaning from mechanical ventilation. However, limited evidence exists regarding the prognostic value of serial dynamic assessment of diaphragmatic function in patients with septic shock from the early stages of ICU admission.

Dynamic changes in diaphragmatic function may provide more clinically meaningful information than a single measurement. Therefore, serial POCUS assessment may help identify patients at high risk of respiratory failure and predict important clinical outcomes.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age ≥ 18 years old.
  • Patients with septic shock.
  • Patients with ICU admission during study period.
  • Expected ICU stay for at least 72 hours.
  • Informed consent from the patient or legal guardian when required.

Exclusion criteria

  • Age less than 18 years old.
  • Pre-existing neuromuscular disorders affecting respiratory muscles.
  • Known diaphragmatic paralysis or diaphragmatic palsy.
  • Significant phrenic nerve injury.
  • Cervical spinal cord injury.
  • Advanced chronic neuromuscular disease.
  • Previous major thoracic or diaphragmatic surgery.
  • Severe chest wall deformity.
  • Conditions preventing adequate diaphragmatic ultrasound assessment.
  • Pregnancy, if required by local ethical policy.
  • Patients with limitations of care that preclude full respiratory support.
  • Refusal of consent where consent is required.

Treatment and study plan

Primary outcomes

  1. Number of participants Developing Respiratory Failure Requiring Invasive Mechanical Ventilation.

    Time frame: From Baseline through Day 7

    Number of participants who develop respiratory failure requiring initiation of invasive mechanical ventilation, assessed by clinical criteria and the requirement for endotracheal intubation and invasive mechanical ventilation.

  2. Diaphragmatic Excursion Measured by Point of Care ultrasound

    Time frame: Baseline, 24 hours, 48 hours, and 72 hours

    Diaphragmatic Excursion measured using M mode point of care ultrasound during spontaneous breathing or ventilator supported breathing, as applicable and measured in millimeter. Three measurements will be obtained and averaged.

  3. Diaphragmatic Thickness Measured by Point of Care Ultrasound

    Time frame: Baseline, 24 hours, 48 hours, and 72 hours

    Diaphragmatic thickness measured at the zone of apposition using B mode point of care ultrasound at end expiration and measured in millimeter. Three measurements will be obtained and averaged.

  4. Diaphragmatic Thickening Fraction Measured by Point of Care Ultrasound

    Time frame: Baseline, 24 hours, 48 hours, and 72 hours

    Diaphragmatic thickening fraction measured using point of care ultrasound and calculated as [(inspiratory thickness-expiratory thickness) / expiratory thickness] * 100 and measured in percentage. Three measurements will be obtained and averaged.

Secondary outcomes

  1. Time to Initiation of Invasive Mechanical Ventilation

    Time frame: From baseline through Day 7

    Time from study enrollment to initiation of invasive mechanical ventilation, measured in hours

  2. Duration of invasive mechanical ventilation

    Time frame: From initiation of invasive mechanical ventilation until successful discontinuation of invasive mechanical ventilation, assessed through ICU discharge or up to 28 days, whichever comes first.

    Duration of invasive mechanical ventilation, calculated from the initiation of invasive mechanical ventilation until successful discontinuation of mechanical ventilation, measured in days.

  3. Number of Participants with Weaning failure

    Time frame: From the first spontaneous breathing trial until successful liberation from invasive mechanical ventilation or ICU discharge, assessed up to 28 days.

    Number of participants who fail the initial attempt to discontinue invasive mechanical ventilation according to predefined clinical criteria and subsequently require continuation or resumption of mechanical ventilatory support.

  4. Number of Participants With Extubation failure

    Time frame: within 72 hours after extubation.

    Number of participants requiring reintubation and reinstitution of invasive mechanical ventilation following planned extubation.

  5. Duration of Intensive Care Unit stay

    Time frame: From baseline (ICU admission) until ICU discharge or death, assessed up to 28 days.

    Duration of stay in the intensive care unit from ICU admission until ICU discharge, measured in days.

  6. Number of Participants Who Die During Intensive Care Unit Stay

    Time frame: From baseline (ICU admission) until ICU discharge or death, assessed up to 28 days.

    Number of participants who die during the Intensive Care Unit stay

Study contacts

Contact information is provided by the study sponsor or research team.

Abdallah Gamal Abd El Hafeez, Master

CONTACT

[email protected]

+0201221248314

Dina Ali Ahmed, MD

CONTACT

[email protected]

+0201063040703

Sponsors and collaborators

Lead sponsor

Assiut University

Other

Registry information

Official study title

Dynamic Point of Care Ultrasound (POCUS) Imaging Assessment of Diaphragmatic Function as a Predictor of Respiratory Failure and Clinical Outcomes in Patients With Septic Shock.

Acronym: POCUS in RF

Important dates

Study start
2026
Primary completion
2028
Study completion
2028
First posted
Sep 15, 2026
Registry last updated
Sep 15, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.